Global Inflammatory Bowel Disease Therapy Market Research Report 2023

Report ID: 1875878 | Published Date: Oct 2024 | No. of Page: 84 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Ulcerative Colitis
        1.2.3 Crohns Disease
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Inflammatory Bowel Disease Therapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Medical Research Organization
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Inflammatory Bowel Disease Therapy Market Perspective (2017-2028)
    2.2 Inflammatory Bowel Disease Therapy Growth Trends by Region
        2.2.1 Inflammatory Bowel Disease Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Inflammatory Bowel Disease Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Inflammatory Bowel Disease Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Inflammatory Bowel Disease Therapy Market Dynamics
        2.3.1 Inflammatory Bowel Disease Therapy Industry Trends
        2.3.2 Inflammatory Bowel Disease Therapy Market Drivers
        2.3.3 Inflammatory Bowel Disease Therapy Market Challenges
        2.3.4 Inflammatory Bowel Disease Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue
        3.1.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue (2017-2022)
        3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Inflammatory Bowel Disease Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapy Revenue
    3.4 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio
        3.4.1 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapy Revenue in 2021
    3.5 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served
    3.6 Key Players Inflammatory Bowel Disease Therapy Product Solution and Service
    3.7 Date of Enter into Inflammatory Bowel Disease Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease Therapy Breakdown Data by Type
    4.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2023-2028)
5 Inflammatory Bowel Disease Therapy Breakdown Data by Application
    5.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Inflammatory Bowel Disease Therapy Market Size (2017-2028)
    6.2 North America Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)
    6.3 North America Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Inflammatory Bowel Disease Therapy Market Size (2017-2028)
    7.2 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)
    7.3 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Inflammatory Bowel Disease Therapy Market Size (2017-2028)
    9.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)
    9.3 Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Company Detail
        11.1.2 Johnson & Johnson Business Overview
        11.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Introduction
        11.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.1.5 Johnson & Johnson Recent Development
    11.2 AbbVie
        11.2.1 AbbVie Company Detail
        11.2.2 AbbVie Business Overview
        11.2.3 AbbVie Inflammatory Bowel Disease Therapy Introduction
        11.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.2.5 AbbVie Recent Development
    11.3 Takeda Pharmaceutical Company
        11.3.1 Takeda Pharmaceutical Company Company Detail
        11.3.2 Takeda Pharmaceutical Company Business Overview
        11.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Introduction
        11.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.3.5 Takeda Pharmaceutical Company Recent Development
    11.4 Abbott
        11.4.1 Abbott Company Detail
        11.4.2 Abbott Business Overview
        11.4.3 Abbott Inflammatory Bowel Disease Therapy Introduction
        11.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.4.5 Abbott Recent Development
    11.5 Celgene Corporation
        11.5.1 Celgene Corporation Company Detail
        11.5.2 Celgene Corporation Business Overview
        11.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Introduction
        11.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.5.5 Celgene Corporation Recent Development
    11.6 Innovate Biopharma
        11.6.1 Innovate Biopharma Company Detail
        11.6.2 Innovate Biopharma Business Overview
        11.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Introduction
        11.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.6.5 Innovate Biopharma Recent Development
    11.7 Cosmo Pharmaceuticals
        11.7.1 Cosmo Pharmaceuticals Company Detail
        11.7.2 Cosmo Pharmaceuticals Business Overview
        11.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Introduction
        11.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.7.5 Cosmo Pharmaceuticals Recent Development
    11.8 Gilead Sciences
        11.8.1 Gilead Sciences Company Detail
        11.8.2 Gilead Sciences Business Overview
        11.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Introduction
        11.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.8.5 Gilead Sciences Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Inflammatory Bowel Disease Therapy Introduction
        11.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)
        11.9.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Ulcerative Colitis
    Table 3. Key Players of Crohns Disease
    Table 4. Key Players of Others
    Table 5. Global Inflammatory Bowel Disease Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Inflammatory Bowel Disease Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Inflammatory Bowel Disease Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Inflammatory Bowel Disease Therapy Market Share by Region (2017-2022)
    Table 9. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Inflammatory Bowel Disease Therapy Market Share by Region (2023-2028)
    Table 11. Inflammatory Bowel Disease Therapy Market Trends
    Table 12. Inflammatory Bowel Disease Therapy Market Drivers
    Table 13. Inflammatory Bowel Disease Therapy Market Challenges
    Table 14. Inflammatory Bowel Disease Therapy Market Restraints
    Table 15. Global Inflammatory Bowel Disease Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Inflammatory Bowel Disease Therapy Market Share by Players (2017-2022)
    Table 17. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2021)
    Table 18. Ranking of Global Top Inflammatory Bowel Disease Therapy Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Inflammatory Bowel Disease Therapy Product Solution and Service
    Table 22. Date of Enter into Inflammatory Bowel Disease Therapy Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2017-2022)
    Table 26. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2023-2028)
    Table 28. Global Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Application (2017-2022)
    Table 30. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Application (2023-2028)
    Table 32. North America Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Johnson & Johnson Company Detail
    Table 43. Johnson & Johnson Business Overview
    Table 44. Johnson & Johnson Inflammatory Bowel Disease Therapy Product
    Table 45. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 46. Johnson & Johnson Recent Development
    Table 47. AbbVie Company Detail
    Table 48. AbbVie Business Overview
    Table 49. AbbVie Inflammatory Bowel Disease Therapy Product
    Table 50. AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 51. AbbVie Recent Development
    Table 52. Takeda Pharmaceutical Company Company Detail
    Table 53. Takeda Pharmaceutical Company Business Overview
    Table 54. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Product
    Table 55. Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 56. Takeda Pharmaceutical Company Recent Development
    Table 57. Abbott Company Detail
    Table 58. Abbott Business Overview
    Table 59. Abbott Inflammatory Bowel Disease Therapy Product
    Table 60. Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 61. Abbott Recent Development
    Table 62. Celgene Corporation Company Detail
    Table 63. Celgene Corporation Business Overview
    Table 64. Celgene Corporation Inflammatory Bowel Disease Therapy Product
    Table 65. Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 66. Celgene Corporation Recent Development
    Table 67. Innovate Biopharma Company Detail
    Table 68. Innovate Biopharma Business Overview
    Table 69. Innovate Biopharma Inflammatory Bowel Disease Therapy Product
    Table 70. Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 71. Innovate Biopharma Recent Development
    Table 72. Cosmo Pharmaceuticals Company Detail
    Table 73. Cosmo Pharmaceuticals Business Overview
    Table 74. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Product
    Table 75. Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 76. Cosmo Pharmaceuticals Recent Development
    Table 77. Gilead Sciences Company Detail
    Table 78. Gilead Sciences Business Overview
    Table 79. Gilead Sciences Inflammatory Bowel Disease Therapy Product
    Table 80. Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 81. Gilead Sciences Recent Development
    Table 82. Pfizer Company Detail
    Table 83. Pfizer Business Overview
    Table 84. Pfizer Inflammatory Bowel Disease Therapy Product
    Table 85. Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)
    Table 86. Pfizer Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Inflammatory Bowel Disease Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Ulcerative Colitis Features
    Figure 3. Crohns Disease Features
    Figure 4. Others Features
    Figure 5. Global Inflammatory Bowel Disease Therapy Market Share by Application in 2021 & 2028
    Figure 6. Hospital Case Studies
    Figure 7. Medical Research Organization Case Studies
    Figure 8. Other Case Studies
    Figure 9. Inflammatory Bowel Disease Therapy Report Years Considered
    Figure 10. Global Inflammatory Bowel Disease Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Inflammatory Bowel Disease Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Inflammatory Bowel Disease Therapy Market Share by Region: 2021 VS 2028
    Figure 13. Global Inflammatory Bowel Disease Therapy Market Share by Players in 2021
    Figure 14. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapy Revenue in 2021
    Figure 16. North America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Inflammatory Bowel Disease Therapy Market Share by Country (2017-2028)
    Figure 18. United States Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Inflammatory Bowel Disease Therapy Market Share by Country (2017-2028)
    Figure 22. Germany Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Inflammatory Bowel Disease Therapy Market Share by Region (2017-2028)
    Figure 30. China Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Inflammatory Bowel Disease Therapy Market Share by Country (2017-2028)
    Figure 38. Mexico Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Inflammatory Bowel Disease Therapy Market Share by Country (2017-2028)
    Figure 42. Turkey Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 45. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 46. Takeda Pharmaceutical Company Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 47. Abbott Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 48. Celgene Corporation Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 49. Innovate Biopharma Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 50. Cosmo Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 51. Gilead Sciences Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 52. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson
AbbVie
Takeda Pharmaceutical Company
Abbott
Celgene Corporation
Innovate Biopharma
Cosmo Pharmaceuticals
Gilead Sciences
Pfizer
Frequently Asked Questions
Inflammatory Bowel Disease Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inflammatory Bowel Disease Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inflammatory Bowel Disease Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Thrombolytic Drug

This report aims to provide a comprehensive presentation of the global market for Thrombolytic Dr ... Read More